Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/13
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 03/31/13
End: 05/31/13
Due: 05/31/14
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 11/30/07
End: 02/29/08
Due: 02/28/09
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Safety Study of VBY-036 in Healthy Volunteers After 7 Days of Oral Dosing | NCT01892891 | Virobay Inc. | user2@example.com | None | 2013-07-31 | 2013-11-30 | 2014-11-30 | - | - | 2025-07-14 |
| Safety Study of VBY-891 in Healthy Volunteers After Single or Multiple (7 Days) of Oral Dosing (VBY891P1) | NCT01947738 | Virobay Inc. | user2@example.com | None | 2013-03-31 | 2013-05-31 | 2014-05-31 | - | - | 2025-07-14 |
| Safety Study of Single Oral Doses of VBY-036 in Healthy Volunteers (VBY036P1A) | NCT01911637 | Virobay Inc. | user2@example.com | None | 2013-05-31 | 2013-07-31 | 2014-07-31 | - | - | 2025-07-14 |
| Evaluation of Safety and Pharmacokinetics of Single Doses of VBY-376 in Healthy Adults | NCT00557583 | Virobay Inc. | user2@example.com | None | 2007-11-30 | 2008-02-29 | 2009-02-28 | - | - | 2025-07-14 |